GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alliance Pharma PLC (LSE:APH) » Definitions » Selling, General, & Admin. Expense

Alliance Pharma (LSE:APH) Selling, General, & Admin. Expense : £63.9 Mil (TTM As of Jun. 2023)


View and export this data going back to 2001. Start your Free Trial

What is Alliance Pharma Selling, General, & Admin. Expense?

Selling, general, & admin. expense (SGA) includes the direct and indirect costs and all general and administrative expenses of a company. Alliance Pharma's selling, general, & admin. expense for the six months ended in Jun. 2023 was £29.2 Mil. Its selling, general, & admin. expense for the trailing twelve months (TTM) ended in Jun. 2023 was £63.9 Mil.


Alliance Pharma Selling, General, & Admin. Expense Historical Data

The historical data trend for Alliance Pharma's Selling, General, & Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alliance Pharma Selling, General, & Admin. Expense Chart

Alliance Pharma Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Selling, General, & Admin. Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 41.93 46.35 44.61 63.05 63.59

Alliance Pharma Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Selling, General, & Admin. Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 28.47 34.58 28.82 34.77 29.18

Competitive Comparison of Alliance Pharma's Selling, General, & Admin. Expense

For the Drug Manufacturers - Specialty & Generic subindustry, Alliance Pharma's Selling, General, & Admin. Expense, along with its competitors' market caps and Selling, General, & Admin. Expense data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alliance Pharma's Selling, General, & Admin. Expense Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Alliance Pharma's Selling, General, & Admin. Expense distribution charts can be found below:

* The bar in red indicates where Alliance Pharma's Selling, General, & Admin. Expense falls into.



Alliance Pharma Selling, General, & Admin. Expense Calculation

Selling, General, & Admin. Expense (SGA) includes the direct and indirect costs and all general and administrative expenses of a company. For instance, personnel cost, advertising, rent, communication costs are all part of SGA.

Selling, General, & Admin. Expense for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was £63.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Alliance Pharma  (LSE:APH) Selling, General, & Admin. Expense Explanation

An efficient operation keeps SGA costs low and thus has higher profit margin. The percentage of SGA relative to total revenue is an indication of how efficiently the company operates. Compare this percentage among the companies in the same industry is a good way of finding more efficient operations. A comparison of the SGA cost relative to the revenue with the historical value can also be an indication of how efficient the company has become.

Warren Buffett likes companies with consistent SGA as the percentage of gross profit.

Companies with no durable competitive advantage show wild variation in SG&A as % of Gross Profit.

If SGA is less than 30% of Gross Profit, it is fantastic. If SGA is nearing 100%, it is is in highly competitive industry.


Alliance Pharma Selling, General, & Admin. Expense Related Terms

Thank you for viewing the detailed overview of Alliance Pharma's Selling, General, & Admin. Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Alliance Pharma (LSE:APH) Business Description

Industry
Traded in Other Exchanges
Address
Bath Road, Avonbridge House, Chippenham, Wiltshire, GBR, SN15 2BB
Alliance Pharma PLC is a player in the healthcare market. The company's business includes the acquisition, marketing, and distribution of consumer healthcare and pharmaceutical products. The group operates in two segments: Consumer Healthcare brands and Prescription Medicines. It generates the majority of its revenue from the Consumer Healthcare segment. Its products include Aloclair, Biodermatin, Changmin, Decapional, Effadiane, and Fazol. The company generates maximum revenue from the Kelo-cote brand. Geographically, it derives a majority of its revenue from Europe, the Middle East, and Africa (EMEA).

Alliance Pharma (LSE:APH) Headlines

From GuruFocus

Q4 2019 Amphenol Corp Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q3 2023 Amphenol Corp Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q4 2020 Amphenol Corp Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q2 2021 Amphenol Corp Earnings Call Transcript

By GuruFocus Research 01-22-2024

The Amphenol Corp (APH) Company: A Short SWOT Analysis

By GuruFocus Research 10-30-2023

Q3 2020 Amphenol Corp Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q2 2023 Amphenol Corp Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q3 2022 Amphenol Corp Earnings Call Transcript

By GuruFocus Research 01-22-2024